Risk of Treatment Failure Within Certain Follow-Up Periods, Depending on Trial
Censored patients are patients who were lost during the specific follow-up period. The upper error bar indicates the trial with the highest incidence of treatment failure in the certain follow-up period. The middle line refers to the trial with the intermediate incidence of treatment failure. The lower error bar indicates the trial that had the lowest incidence of treatment failure. CAO 04 indicates CAO/ARO/AIO-04 trial; CAO 12, CAO/ARO/AIO-12 trial; and CAO 94, CAO/ARO/AIO-94 trial.The risk of treatment failure was associated with the pathologic ypTNM stage. Within the first 12 months after randomization, 22% of patients with ypN+ experienced treatment failure vs only 1% of patients with a pathologic complete response (pCR) (